Rare Variants in Pharmacogenes Influence Clozapine Metabolism in Individuals with Schizophrenia
Djenifer B. Kappel, Elliott Rees, Eilidh Fenner, Adrian King, John Jansen, Marinka Helthuis, Michael John Owen, Michael C. O’Donovan, James Walters, Antonio F. Pardiñas
This study identifies rare genetic variants in pharmacogenes that influence clozapine metabolism in schizophrenia patients, with CYP1A2 variants showing the strongest effect.
European Neuropsychopharmacology · Feb 3, 2024Peer-reviewedGenetic & Genomic Medicine